Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Assets Average (2016 - 2025)

Historic Assets Average for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $238.7 million.

  • Abeona Therapeutics' Assets Average rose 8748.52% to $238.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.7 million, marking a year-over-year increase of 8748.52%. This contributed to the annual value of $86.5 million for FY2024, which is 3487.63% up from last year.
  • As of Q3 2025, Abeona Therapeutics' Assets Average stood at $238.7 million, which was up 8748.52% from $172.8 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Assets Average registered a high of $238.7 million during Q3 2025, and its lowest value of $41.7 million during Q3 2022.
  • Its 5-year average for Assets Average is $99.2 million, with a median of $99.3 million in 2021.
  • In the last 5 years, Abeona Therapeutics' Assets Average tumbled by 6656.71% in 2022 and then soared by 11280.62% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Assets Average (Quarter) stood at $99.3 million in 2021, then plummeted by 48.15% to $51.5 million in 2022, then rose by 26.33% to $65.0 million in 2023, then skyrocketed by 76.44% to $114.8 million in 2024, then skyrocketed by 107.97% to $238.7 million in 2025.
  • Its Assets Average stands at $238.7 million for Q3 2025, versus $172.8 million for Q2 2025 and $104.1 million for Q1 2025.